Skip to main content
. 2023 Sep 29;14(5):e01180-23. doi: 10.1128/mbio.01180-23

Fig 6.

Fig 6

BYP41 shows an improved survival in systemic infection mice treated with humanized dose of caspfungin (5 mg/kg) administered 2 h prior (A and B) or 4 h post infection (C and D).